PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,650,836 | -20.7% | 40,591 | -5.6% | 0.00% | -25.0% |
Q1 2023 | $2,081,903 | +44.2% | 42,979 | +13.6% | 0.00% | +33.3% |
Q4 2022 | $1,443,971 | -26.2% | 37,830 | -2.9% | 0.00% | -25.0% |
Q3 2022 | $1,956,000 | +17.8% | 38,961 | -6.0% | 0.00% | 0.0% |
Q2 2022 | $1,661,000 | -1.0% | 41,468 | -7.7% | 0.00% | +33.3% |
Q1 2022 | $1,677,000 | -4.3% | 44,938 | +2.1% | 0.00% | 0.0% |
Q4 2021 | $1,753,000 | +6.6% | 44,007 | -0.5% | 0.00% | 0.0% |
Q3 2021 | $1,645,000 | -12.5% | 44,216 | -0.6% | 0.00% | -25.0% |
Q2 2021 | $1,881,000 | +10.3% | 44,500 | +23.6% | 0.00% | 0.0% |
Q1 2021 | $1,705,000 | -51.8% | 36,000 | -37.9% | 0.00% | -55.6% |
Q4 2020 | $3,536,000 | +31.8% | 57,937 | +1.0% | 0.01% | +12.5% |
Q3 2020 | $2,682,000 | -39.2% | 57,366 | -34.0% | 0.01% | -42.9% |
Q2 2020 | $4,412,000 | +51.9% | 86,949 | +33.6% | 0.01% | +27.3% |
Q1 2020 | $2,904,000 | +194.8% | 65,087 | +217.5% | 0.01% | +266.7% |
Q4 2019 | $985,000 | +603.6% | 20,500 | +451.8% | 0.00% | – |
Q1 2019 | $140,000 | -52.4% | 3,715 | -40.6% | 0.00% | -100.0% |
Q4 2018 | $294,000 | 0.0% | 6,255 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $294,000 | +764.7% | 6,255 | +525.5% | 0.00% | – |
Q2 2018 | $34,000 | +25.9% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $27,000 | +58.8% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $17,000 | -22.7% | 1,000 | -10.3% | 0.00% | – |
Q3 2017 | $22,000 | +22.2% | 1,115 | +11.5% | 0.00% | – |
Q2 2017 | $18,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | -97.3% | 1,000 | -96.5% | 0.00% | -100.0% |
Q3 2016 | $404,000 | +98.0% | 28,869 | -0.7% | 0.00% | +100.0% |
Q2 2016 | $204,000 | +83.8% | 29,081 | +67.7% | 0.00% | 0.0% |
Q1 2016 | $111,000 | -91.6% | 17,340 | -57.7% | 0.00% | -87.5% |
Q4 2015 | $1,329,000 | -14.9% | 41,009 | -29.9% | 0.01% | -42.9% |
Q3 2015 | $1,561,000 | -35.6% | 58,474 | +16.1% | 0.01% | -36.4% |
Q2 2015 | $2,424,000 | +58.7% | 50,368 | +100.5% | 0.02% | +69.2% |
Q1 2015 | $1,527,000 | – | 25,116 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |